WO2009042796A2 - Alignment stent apparatus and method - Google Patents

Alignment stent apparatus and method Download PDF

Info

Publication number
WO2009042796A2
WO2009042796A2 PCT/US2008/077727 US2008077727W WO2009042796A2 WO 2009042796 A2 WO2009042796 A2 WO 2009042796A2 US 2008077727 W US2008077727 W US 2008077727W WO 2009042796 A2 WO2009042796 A2 WO 2009042796A2
Authority
WO
WIPO (PCT)
Prior art keywords
stent
graft
belt
free end
vessel
Prior art date
Application number
PCT/US2008/077727
Other languages
French (fr)
Other versions
WO2009042796A3 (en
Inventor
Michael V. Chobotov
Issac J. Zacharias
Diego Aristizabal
Michael Mohn
Original Assignee
Trivascular2, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/861,746 external-priority patent/US20090082845A1/en
Priority claimed from US11/861,716 external-priority patent/US8066755B2/en
Application filed by Trivascular2, Inc. filed Critical Trivascular2, Inc.
Priority to EP08834027.8A priority Critical patent/EP2194919A4/en
Publication of WO2009042796A2 publication Critical patent/WO2009042796A2/en
Publication of WO2009042796A3 publication Critical patent/WO2009042796A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • A61F2002/8483Barbs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • A61F2002/9511Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument the retaining means being filaments or wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/005Rosette-shaped, e.g. star-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Definitions

  • the present invention relates to a system for the treatment of disorders of the vasculature. More specifically, the invention relates to a system for the treatment of disease or injury that potentially compromises the integrity of a flow conduit in the body.
  • an embodiment of the invention is useful in treating indications in the digestive and reproductive systems as well as indications in the cardiovascular system, including thoracic and abdominal aortic aneurysms, arterial dissections (such as those caused by traumatic injury), etc. that include a curved lumen.
  • a stent typically is an elongated device used to support an intraluminal wall.
  • a stent provides an unobstructed conduit through a body lumen in the area of the stenosis.
  • Such a stent may also have a prosthetic graft layer of fabric or covering lining the inside and/or outside thereof.
  • a covered stent is commonly referred to in the art as an intraluminal prosthesis, an endoluminal or endovascular graft (EVG), a stent-graft, or endograft.
  • An endograft may be used, for example, to treat a vascular aneurysm by removing or reducing the pressure on a weakened part of an artery so as to reduce the risk of rupture.
  • an endograft is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e. by so-called "minimally invasive techniques" in which the endograft, typically restrained in a radially compressed configuration by a sheath, crocheted or knit web, catheter or other means, is delivered by an endograft delivery system or "introducer" to the site where it is required.
  • the introducer may enter the vessel or lumen from an access location outside the body, such as purcutaneously through the patient's skin, or by a "cut down” technique in which the entry vessel or lumen is exposed by minor surgical means.
  • proximal refers to portions of the endograft, stent or delivery system relatively closer to the end outside of the body, whereas the term “distal” is used to refer to portions relatively closer to the end inside the body.
  • AAA thorasic aortic aneurysm
  • AAA abdominal aortic aneurysm
  • An AAA is an area of increased aortic diameter that generally extends from just below the renal arteries to the aortic bifurcation and a TAA most often occurs in the descending thoracic aorta.
  • AAA and TAA generally result from deterioration of the arterial wall, causing a decrease in the structural and elastic properties of the artery. In addition to a loss of elasticity, this deterioration also causes a slow and continuous dilation of the lumen.
  • AAA or TAA The standard surgical repair of AAA or TAA is an extensive and invasive procedure typically requiring a week long hospital stay and an extended recovery period.
  • the practitioner deploys the endograft, anchoring it above and below the aneurysm to relatively healthy tissue.
  • the anchored endograft diverts blood flow away from the weakened arterial wall, minimizing the exposure of the aneurysm to high pressure.
  • Intraluminal stents for repairing a damaged or diseased artery or to be used in conjunction with a graft for delivery to an area of a body lumen that has been weakened by disease or damaged, such as an aneurysm of the thorasic or abdominal aorta, are well established in the art of medical science. While intraluminal stents are advantageous in anchoring the device, an improved system for aligning stents in curved vessels or lumens is desired.
  • the invention provides a stent-graft system comprising a graft member and a single segment stent having a connection end interconnected with the graft member and a free end opposed thereto.
  • a belt retaining structure is provided at the stent free end.
  • a belt is releasably retained in the belt retaining structure and is configured to constrain the stent free end independent of the stent connection end.
  • the invention provides a method of securing at least one end of a graft within a vessel.
  • the method comprises: positioning within the vessel a stent-graft comprising a single segment stent and a graft with a connection end of the stent connected to an end of the graft, the stent having a free end opposite the connection end, the stent free end including a belt retaining structure with a belt releasably retained thereabout; deploying the stent connection end within the vessel; repositioning the stent-graft within the vessel; and releasing the belt to deploy the free end of the stent.
  • the invention provides a stent-graft system comprising a graft member and a stent having a connection end interconnected with the graft member and a free end opposed thereto.
  • a belt retaining structure is provided at the stent free end.
  • a belt is releasably retained in the belt retaining structure and is configured to constrain the stent free end independent of the stent connection end.
  • the invention provides a method of securing at least one end of a graft within a vessel.
  • the method comprises: positioning within the vessel a stent-graft comprising a stent and a graft with a connection end of the stent connected to an end of the graft, the stent having a free end opposite the connection end, the stent free end including a belt retaining structure with a belt releasably retained thereabout; deploying the stent connection end within the vessel; repositioning the stent-graft within the vessel; and releasing the belt to deploy the free end of the stent.
  • Fig. 1 shows a portion of an endovascular graft according to an embodiment of the present invention in a contracted state for delivery through a catheter.
  • Fig. 2 shows a flat pattern of an embodiment of a stent in accordance with the present invention.
  • Fig. 3 shows a portion of an endovascular graft according to an embodiment of the present invention partially deployed within an aortic arch of the patient.
  • Fig. 4 shows the endovascular graft portion of Fig. 3 fully deployed within the internal vasculature of the patient.
  • Fig. 5 shows a portion of an endovascular graft according to an embodiment of the present invention in a contracted state for delivery through a catheter.
  • Fig. 6 shows a flat pattern of an embodiment of a stent in accordance with the present invention.
  • Fig. 7 shows a flat pattern of an alternative embodiment of a stent in accordance with the present invention.
  • Fig. 8 shows a flat pattern of another alternative embodiment of a stent in accordance with the present invention.
  • Fig. 9 shows a portion of an endovascular graft according to an embodiment of the present invention partially deployed within the internal vasculature of the patient.
  • Fig. 10 shows the endovascular graft portion of Fig. 9 fully deployed within the internal vasculature of the patient.
  • Fig. 1 1 shows a portion of an endovascular graft according to an embodiment of the present invention partially deployed within an aortic arch of the patient.
  • Fig. 12 is an isometric view of a pivot fitting in accordance with another embodiment of the present invention.
  • Fig. 13 is an end view of the pivot fitting of Fig. 12.
  • Fig. 14 is a cross-sectional view along the line 14-14 in Fig. 13.
  • Fig. 15 is a cross-sectional view similar to Fig. 14 illustrating schematically a stent thereon in a contracted state.
  • Fig. 16 is a cross-sectional view similar to Fig. 14 illustrating schematically a stent thereon in a partially deployed state.
  • Fig. 17 is a perspective view illustrating a stent in the partially deployed state of Fig. 16.
  • graft or "endovascular graft” is used herein to refer to a prosthesis capable of repairing and/or replacing diseased vessels or portions thereof, including generally tubular and bifurcated devices and any components attached or integral thereto.
  • graft embodiments described herein may be used in the endovascular treatment of abdominal aortic aneurysms (AAA) or thoracic aortic aneurysms, however, other applications are within the scope of the present invention.
  • AAA abdominal aortic aneurysms
  • thoracic aortic aneurysms thoracic aortic aneurysms
  • proximal describes the end of the graft that will be oriented towards the oncoming flow of bodily fluid, typically blood, when the device is deployed within a body passageway.
  • distal therefore describes the graft end opposite the proximal end.
  • the graft 10 includes a generally tubular structure or graft body section 13 comprised of one or more layers of fusible material, such as expanded polytetrafluoroethylene (ePTFE).
  • An inflatable cuff 16 is disposed at or near the end 14 of graft body section 13.
  • a neck portion 23 is disposed in the vicinity of graft body section end 14 and serves as an additional means to help seal the deployed graft against the inside of a body passageway.
  • Graft body section 13 forms a longitudinal lumen 22 configured to confine a flow of fluid therethrough.
  • attachment ring 24 is affixed to or integrally formed in graft body section 13, or as shown in Fig. 1 , at or near graft body section end 14 and neck portion 23.
  • attachment ring 24 is a serpentine ring structure comprising apices 28.
  • Other embodiments of attachment ring 24 may take different configurations.
  • Attachment ring 24 may be made from any suitable material that permits expansion from a constrained state, most usefully a shape memory alloy having superelastic properties such as nickel titanium (NiTi).
  • suitable attachment ring 24 materials include stainless steel, nickel-cobalt alloys such as MP35N, tantalum and its alloys, polymeric materials, composites, and the like. Attachment ring 24 (as well as all stents and attachment rings described herein) may be configured to self-expand from the illustrated radially constrained state.
  • Some apices 28 may also comprise a attachment ring connector element not shown).
  • the number of connector elements may vary and can be distributed, for example, on every apex, every third or fourth apex, or any other pattern are within the scope of the present invention.
  • Graft 10 further comprises one or more stents 40 having, in the deployed state (see Fig. 4), a generally free end 42 and a connection end 44.
  • Figs. 1 -4 illustrate a proximal stent 40, but the stents 40 may additionally or alternatively be provided on the distal end of the graft 10.
  • the stent 40 is desirably for use in an angulated or curved lumen and is a short aspect raito stent including a single segement.
  • single segment stent it is meant that the stent 40 includes single lengths of struts 41 between the free end 42 and a connection end 44.
  • stent 40 is typically, though not necessarily, made a part of graft 10 by having the connection end 44 affixed or connected to attachment ring 24 via connector elements as described in detail below.
  • the connection end 44 of stent 40 may also be affixed or embedded directly to or in neck portion 23 and/or other portions of graft body section 13.
  • the attachment ring and the stent may not be mechanically or otherwise fastened to one another but rather unified, formed of a monolithic piece of material, such as NiTi. This configuration of stent 40, attachment ring 24, neck portion 23, and cuff
  • the stents 40 of the present invention permit improved positioning of the graft 10 prior to stent anchoring, thereby facilitating better placement and sealing of the graft 10.
  • each stent 40 of the present invention generally comprises a series of interconnected struts 41.
  • the struts 41 can have various configurations and lengths.
  • Each stent 40 further comprises stent connector elements 48 at the connection end 44 thereof.
  • the stent connector elements 48 are configured to be affixed or otherwise connected to attachment ring connector elements via coupling members (not shown), for example, threads or wires.
  • the stents 40 may be manufactured from any suitable material, including the materials suitable for attachment ring 24. When manufactured from a shape memory alloy having superelastic properties such as NiTi, the stents 40 may be configured to self-expand upon release from the contracted state.
  • Each stent 40 includes one or more barbs 43.
  • a barb 43 can be any outwardly directed protuberance, typically terminating in a sharp point that is capable of at least partially penetrating a body passageway in which graft 10 is deployed (typically the initial and medial layers of a blood vessel such as the abdominal aorta).
  • the number of barbs, the length of each barb, each barb angle, and the barb orientation may vary from barb to barb within a single stent 40 or between multiple stents 40 within a single graft.
  • the various barbs 43 may be attached to or fixed on the stent struts 41 , it is preferred that they be integrally formed as part of the stent struts 41 , as shown in the various figures.
  • barbs 43 are designed to work in conjunction with the distally-ohented blood flow field in this location to penetrate tissue and prevent axial migration of graft 10.
  • the barbs 43 in the Fig. 1 embodiment are oriented distally with respect to graft body section 13.
  • Struts 41 may also comprise optional integral tuck pads 45 disposed opposite each barb 43.
  • each barb 43 is placed behind a corresponding strut 41 and/or optional tuck pad 45, if present, to thereby prevent the barbs 43 from contacting the inside of a delivery sheath or catheter during delivery of the device and from undesired contact with the inside of a vessel wall.
  • an initial stage release belt 35 disposed about the struts 41 retain the stent 40 in this delivery configuration.
  • the initial stage release belts 35 retain the contracted stent 40 on a guidewire chassis 12 or the like.
  • the number of initial stage belts 35 varies in accordance with the structure of the stent 40.
  • the stent 40 as illustrated in Figs. 1 -4 is a single segment and includes only one initial stage belt 35 about the proximal end of the stent 40.
  • the stent 40 of the present invention includes a belt retaining structure 50 provided along the crowns 47 at the free end 42 of the stent 40.
  • the belt retaining structure 50 includes a plurality of mushroom shaped connectors 52 extending from the crowns 47.
  • the mushroom shaped connectors 52 may be provided at each crown 47, as illustrated, or in any configuration with respect to the crowns 47. Referring to Figs.
  • a releasable secondary stage belt 53 is positionable about the mushroom shaped connectors 52 to retain the stent free end 42 in a contracted state until the secondary stage belt 53 is released, for example, via a release wire 55.
  • the belt retaining structure 50 includes a through hole 54 provided in a plurality of the crowns 47.
  • a releasable belt (not shown) is threaded through the through holes 54 and pulled tight to retain the stent free end 42 in a contracted state until the belt is released.
  • Other belt retaining structures 50 along the stent free end 42 may also be utilized. As shown in Fig.
  • the stent connection end 44, the attachment ring 24, and the graft 10 expand while the secondary stage belt 53 engages the belt retaining structure 50 and retains the stent free end 42 in the generally contracted condition.
  • the stent connection end 44 and the graft 10 expand based on the self expanding nature of the stent 40 and also the force of the distal fluid flow into the graft 10.
  • the struts 41 and barbs 43 are configured such that when the belt retaining structure 50 is in place and the stent free end 42 is restrained, the barbs 43 do not extend sufficiently radially to engage the vessel wall 20, but instead remain spaced therefrom.
  • the graft 10 and stent 40 may be moved and repositioned without the barbs 43 engaging and damaging the vessel wall 20.
  • the barbs 43 are axially positioned closer to the stent free end 42 than the stent connection end 44 to further ensure the barbs 43 will not contact the vessel wall 20 in the partially deployed state.
  • the release wire 55 may be pulled to release the secondary stage belt 53 from the belt retaining structure 50, thereby allowing the stent 40 to fully deploy as illustrated in Fig. 4.
  • the struts 41 are free to fully radially expand such that the barbs 43 engage the vessel wall 20 in a normal manner.
  • the staged deployment of the stent 40 also facilitates self-alignment of the stent 40 and graft 10.
  • the graft 10 upon release of the initial stage belts 35, the graft 10 is free to expand and distal fluid flow flows into the graft 10 and creates a "windsock" effect. That is, the distal fluid flow expands the graft 10 and applies a slight distal force upon the graft 10. This distal force helps to align the graft 10 and the stent 40 within the vessel.
  • the stent 40 is illustrated partially deployed in an aortic arch 25.
  • the delivery guidewire chassis 12 contacts the vessel wall 20 and does not remain coaxial with respect to the arch 25.
  • the stent 40 may be cocked or otherwise misaligned with respect to the vessel wall 20.
  • the stent would expand and the barbs would engage the vessel wall even if the stent was misaligned.
  • the initial stage belt(s) 35 are released and the stent 40 is partially deployed.
  • graft 10 a portion of an illustrative endovascular graft 1 10, that may include a stent with multiple segments, is shown in its contracted configuration.
  • graft or "endovascular graft” is used herein to refer to a prosthesis capable of repairing and/or replacing diseased vessels or portions thereof, including generally tubular and bifurcated devices and any components attached or integral thereto.
  • the graft embodiments described herein may be used in the endovascular treatment of abdominal aortic aneurysms (AAA) or thoracic aortic aneurysms, however, other applications are within the scope of the present invention.
  • AAA abdominal aortic aneurysms
  • thoracic aortic aneurysms other applications are within the scope of the present invention.
  • proximal describes the end of the graft that will be oriented towards the oncoming flow of bodily fluid, typically blood, when the device is deployed within a body passageway.
  • the term “distal” therefore describes the graft end opposite the proximal end.
  • the graft 1 10 includes a generally tubular structure or graft body section 1 13 comprised of one or more layers of fusible material, such as expanded polytetrafluoroethylene (ePTFE).
  • An inflatable cuff 1 16 is disposed at or near the end 1 14 of graft body section 1 13.
  • a neck portion 123 is disposed in the vicinity of graft body section end 1 14 and serves as an additional means to help seal the deployed graft against the inside of a body passageway.
  • Graft body section 1 13 forms a longitudinal lumen 122 configured to confine a flow of fluid therethrough.
  • a attachment ring 124 is affixed to or integrally formed in graft body section 1 13, or as shown in Fig. 5, at or near graft body section end 1 14 and neck portion 123.
  • attachment ring 124 is a serpentine ring structure comprising apices 128.
  • Other embodiments of attachment ring 124 may take different configurations.
  • Attachment ring 124 may be made from any suitable material that permits expansion from a constrained state, most usefully a shape memory alloy having superelastic properties such as nickel titanium (NiTi).
  • Other suitable attachment ring 124 materials include stainless steel, nickel-cobalt alloys such as MP35N, tantalum and its alloys, polymeric materials, composites, and the like. Attachment ring 124 (as well as all stents and attachment rings described herein) may be configured to self-expand from the illustrated radially constrained state.
  • Some apices 128 may also comprise a attachment ring connector element
  • connector elements 130 may vary and can be distributed, for example, on every apex, every third or fourth apex, or any other pattern are within the scope of the present invention.
  • Graft 1 10 further comprises one or more stents 140 having, in the deployed state (see Fig. 10), a generally free end 142 and a connection end 144.
  • Figs. 5 and 9-10 illustrate a proximal stent 140, but the stents 140 may additionally or alternatively be provided on the distal end of the graft 1 10.
  • a stent 140 may be provided on the distal end of each leg of the bifurcated graft.
  • stent 140 is typically, though not necessarily, made a part of graft 1 10 by having the connection end 144 affixed or connected to attachment ring 124 via connector elements as described in detail below.
  • connection end 144 of stent 140 may also be affixed or embedded directly to or in neck portion 123 and/or other portions of graft body section 1 13.
  • the attachment ring and the stent may not be mechanically or otherwise fastened to one another but rather unified, formed of a monolithic piece of material, such as NiTi.
  • This configuration of stent 140, attachment ring 124, neck portion 123, and cuff 1 16 helps to separate the sealing function of cuff 1 16, which requires conformation and apposition to the vessel wall within which graft 1 10 is deployed without excessive radial force, from the anchoring function of stent 140 (attachment ring 124 and neck portion 123 play intermediate roles).
  • the stents 140 of the present invention permit improved positioning of the graft 1 10 prior to stent anchoring, thereby facilitating better placement and sealing of the graft 1 10.
  • each stent 140 of the present invention generally comprises a series of interconnected struts 141. As illustrated, the struts 141 can have various configurations and lengths. Each stent 140 further comprises stent connector elements 148 at the connection end 144 thereof. The stent connector elements 148 are configured to be affixed or otherwise connected to attachment ring connector elements 130 via coupling members (not shown), for example, threads or wires.
  • the stents 140 may be manufactured from any suitable material, including the materials suitable for attachment ring 124. When manufactured from a shape memory alloy having superelastic properties such as NiTi, the stents 140 may be configured to self-expand upon release from the contracted state.
  • the strut structure is often formed as a flat structure, as illustrated in Figs. 6-8, and thereafter, wrapped and connected in a cylindrical or other configuration, as illustrated in Fig. 5.
  • Each stent 140 includes one or more barbs 143.
  • a barb 143 can be any outwardly directed protuberance, typically terminating in a sharp point that is capable of at least partially penetrating a body passageway in which graft 1 10 is deployed (typically the initial and medial layers of a blood vessel such as the abdominal aorta).
  • the number of barbs, the length of each barb, each barb angle, and the barb orientation may vary from barb to barb within a single stent 140 or between multiple stents 140 within a single graft.
  • the various barbs 143 may be attached to or fixed on the stent struts 141 , it is preferred that they be integrally formed as part of the stent struts 141 , as shown in the various figures.
  • barbs 143 are designed to work in conjunction with the distally-ohented blood flow field in this location to penetrate tissue and prevent axial migration of graft 1 10.
  • the barbs 143 in the Fig. 5 embodiment are oriented distally with respect to graft body section 1 13.
  • the number, dimensions, configuration and orientation of barbs 143 may vary significantly, yet be within the scope of the present invention.
  • Struts 141 may also comprise optional integral tuck pads 145 disposed opposite each barb 143.
  • each barb 143 is placed behind a corresponding strut 141 and/or optional tuck pad 145, if present, to thereby prevent the barbs 143 from contacting the inside of a delivery sheath or catheter during delivery of the device and from undesired contact with the inside of a vessel wall.
  • an initial stage release belt 135 disposed about the struts 141 retain the stent 140 in this delivery configuration.
  • the initial stage release belts 135 retain the contracted stent 140 on a guidewire chassis 1 12 or the like.
  • the number of initial stage belts 135 varies in accordance with the structure of the stent 140.
  • the stents 140 as illustrated in Figs. 6 and 8 have proximal and distal segments and two corresponding initial stage belts 135, one about the proximal segment and one about the distal segment, are used to secure the stent 140 as shown in Fig. 5.
  • a single initial stage belt 135 is typically used to secure the stent 140.
  • the barbs 143 are freed from behind the struts 141 and optional tuck pads 145, if present, and engage the wall of the vessel being treated.
  • the barbs 143 may be designed to work in conjunction with the distally-ohented blood flow field, that is, the barbs 143 are oriented distally, however, they do not have to be.
  • the barbs 143 at the proximal end are oriented distally, while the barbs 143 at the distal end are oriented proximally.
  • each stent 140 of the present invention includes a belt retaining structure 150 provided along the crowns 147 at the free end 142 of the stent 140.
  • the belt retaining structure 150 includes a plurality of mushroom shaped connectors 152 extending from the crowns 147.
  • the mushroom shaped connectors 152 may be provided at each crown 147, as illustrated, or in any configuration with respect to the crowns 147.
  • a releasable secondary stage belt 153 is positionable about the mushroom shaped connectors 152 to retain the stent free end 142 in a contracted state until the secondary stage belt 153 is released, for example, via a release wire 155.
  • the belt retaining structure 150 includes a through hole 154 provided in a plurality of the crowns 147.
  • a releasable belt (not shown) is threaded through the through holes 154 and pulled tight to retain the stent free end 142 in a contracted state until the belt is released.
  • Other belt retaining structures 150 along the stent free end 142 may also be utilized.
  • the stent connection end 144, the attachment ring 124, and the graft 1 10 expand while the secondary stage belt 153 engages the belt retaining structure 150 and retains the stent free end 142 in the generally contracted condition.
  • the stent connection end 144 and the graft 1 10 expand based on the self expanding nature of the stent 140 and also the force of the distal fluid flow into the graft 1 10.
  • the struts 141 and barbs 143 are configured such that when the belt retaining structure 150 is in place and the stent free end 142 is restrained, the barbs 143 do not extend sufficiently radially to engage the vessel wall 120, but instead remain spaced therefrom.
  • the graft 1 10 and stent 140 may be moved and repositioned without the barbs 143 engaging and damaging the vessel wall 120.
  • the barbs 143 are axially positioned closer to the stent free end 142 than the stent connection end 144 to further ensure the barbs 143 will not contact the vessel wall 120 in the partially deployed state.
  • the staged deployment of the stent 140 also facilitates self- alignment of the stent 140 and graft 1 10.
  • the graft 1 10 is free to expand and distal fluid flow flows into the graft 1 10 and creates a "windsock" effect. That is, the distal fluid flow expands the graft 1 10 and applies a slight distal force upon the graft 1 10. This distal force helps to align the graft 1 10 and the stent 140 within the vessel.
  • a stent graft within an angulated vessel, for example, in the aortic arch.
  • the stent 140 is illustrated partially deployed in an aortic arch 125.
  • the delivery guidewire chassis 1 12 contacts the vessel wall 120 and does not remain coaxial with respect to the arch 125.
  • the stent 140 may be cocked or otherwise misaligned with respect to the vessel wall 120.
  • the stent would expand and the barbs would engage the vessel wall even if the stent was misaligned.
  • the initial stage belt(s) 135 are released and the stent 140 is partially deployed.
  • the distal fluid flow flows into the graft 1 10 and creates the windsock effect, thereby pulling the graft 1 10 and stent 140 into alignment with the flow and thereby the vessel wall 120.
  • the pivot fitting 200 configured to assist in the multi- staged deployment of stent 140 will be described.
  • the pivot fitting 200 has a generally cylindrical body 202 with an axial through bore 204 configured to position the fitting 200 about the guidewire chassis 1 12 (see Fig. 17) or the like.
  • a transverse bore 206 is provided to facilitate positioning and attachment of the pivot fitting 200 about the guidewire chassis 1 12 and loading into the delivery catheter (not shown).
  • the pivot fitting 200 includes an area 208 of reduced cross section extending between a shoulder 210 and a radial belt support member 212.
  • the area 208 is configured to receive the free ends of the stent 140, for example, the mushroom shaped connectors 152 or the crowns 147 with through holes 154.
  • the radial belt support member 212 includes a plurality of radial slots 214. In the embodiment illustrated in Fig. 17, each radial slot 214 receives the narrow neck portion of a respective mushroom shaped connector 152.
  • a circumferential groove 216 is provided along the radial surface of the radial belt support member 212.
  • the circumferential groove 216 is configured to receive and maintain the secondary stage belt 153.
  • a belt radial slot 218 is provided in the radial belt support member 212 to facilitate passage of the secondary stage belt 153 from the guidewire chassis 1 12 or the like outward to the circumferential groove 216.
  • the stent 140 in the delivery stage, the stent 140 is compacted with the free end 142 passing through the radial slots 214 in the radial belt support member 212.
  • the secondary stage belt 153 is secured in the circumferential groove 216 and constrains the stent free end 142.
  • the connection end 144 of the stent 140 upon release of the initial stage release belts 135, the connection end 144 of the stent 140 expands while the free end 142 is retained by the secondary stage belt 153.
  • the opening diameter of the connection end 144 can be controlled by the relation of the outer diameter of area 208 and the inner diameter of the circumferential groove 216 and the length of the portion of the stent free end 142 that extends into area 208.
  • the stent free end 142 is securely retained by the pivot fitting 200, which in turn is connected to the guidewire chassis 1 12. As such, movement of the guidewire chassis 1 12 provides relatively precise control of the position of the stent 140. Once the stent 140 is positioned in a desired position, the secondary stage belt 153 is released and the stent free end 142 disengages from the pivot fitting 200 and expands. The pivot fitting 200 remains connected to the guidewire chassis 1 12 and is removed upon removal thereof.

Abstract

The invention provides a stent-graft system comprising a graft member and a stent having a connection end interconnected with the graft member and a free end opposed thereto. A belt retaining structure is provided at the stent free end. A belt is releasably retained in the belt retaining structure and is configured to constrain the stent free end independent of the stent connection end. A method of securing at least one end of a stent-graft within a vessel is also provided.

Description

ALIGNMENT STENT APPARATUS AND METHOD
Background
The present invention relates to a system for the treatment of disorders of the vasculature. More specifically, the invention relates to a system for the treatment of disease or injury that potentially compromises the integrity of a flow conduit in the body. For example, an embodiment of the invention is useful in treating indications in the digestive and reproductive systems as well as indications in the cardiovascular system, including thoracic and abdominal aortic aneurysms, arterial dissections (such as those caused by traumatic injury), etc. that include a curved lumen.
Medical devices for placement in a human or other animal body are well known in the art. One class of medical devices comprises endoluminal devices such as stents, stent-grafts, filters, coils, occlusion baskets, valves, and the like. A stent typically is an elongated device used to support an intraluminal wall. In the case of a stenosis, for example, a stent provides an unobstructed conduit through a body lumen in the area of the stenosis. Such a stent may also have a prosthetic graft layer of fabric or covering lining the inside and/or outside thereof. A covered stent is commonly referred to in the art as an intraluminal prosthesis, an endoluminal or endovascular graft (EVG), a stent-graft, or endograft.
An endograft may be used, for example, to treat a vascular aneurysm by removing or reducing the pressure on a weakened part of an artery so as to reduce the risk of rupture. Typically, an endograft is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e. by so-called "minimally invasive techniques" in which the endograft, typically restrained in a radially compressed configuration by a sheath, crocheted or knit web, catheter or other means, is delivered by an endograft delivery system or "introducer" to the site where it is required. The introducer may enter the vessel or lumen from an access location outside the body, such as purcutaneously through the patient's skin, or by a "cut down" technique in which the entry vessel or lumen is exposed by minor surgical means. The term "proximal" as used herein refers to portions of the endograft, stent or delivery system relatively closer to the end outside of the body, whereas the term "distal" is used to refer to portions relatively closer to the end inside the body. After the introducer is advanced into the body lumen to the endograft deployment location, the introducer is manipulated to cause the endograft to be deployed from its constrained configuration, whereupon the stent is expanded to a predetermined diameter at the deployment location, and the introducer is withdrawn. Stent expansion typically is effected by spring elasticity, balloon expansion, and/or by the self-expansion of a thermally or stress-induced return of a memory material to a pre-conditioned expanded configuration.
Among the many applications for endografts is that of deployment in lumen for repair of an aneurysm, such as a thorasic aortic aneurysm (TAA) or an abdominal aortic aneurysm (AAA). An AAA is an area of increased aortic diameter that generally extends from just below the renal arteries to the aortic bifurcation and a TAA most often occurs in the descending thoracic aorta. AAA and TAA generally result from deterioration of the arterial wall, causing a decrease in the structural and elastic properties of the artery. In addition to a loss of elasticity, this deterioration also causes a slow and continuous dilation of the lumen. The standard surgical repair of AAA or TAA is an extensive and invasive procedure typically requiring a week long hospital stay and an extended recovery period. To avoid the complications of the surgical procedure, practitioners commonly resort to a minimally invasive procedure using an endoluminal endograft to reinforce the weakened vessel wall, as mentioned above. At the site of the aneurysm, the practitioner deploys the endograft, anchoring it above and below the aneurysm to relatively healthy tissue. The anchored endograft diverts blood flow away from the weakened arterial wall, minimizing the exposure of the aneurysm to high pressure.
Intraluminal stents for repairing a damaged or diseased artery or to be used in conjunction with a graft for delivery to an area of a body lumen that has been weakened by disease or damaged, such as an aneurysm of the thorasic or abdominal aorta, are well established in the art of medical science. While intraluminal stents are advantageous in anchoring the device, an improved system for aligning stents in curved vessels or lumens is desired.
Summary
In one aspect, the invention provides a stent-graft system comprising a graft member and a single segment stent having a connection end interconnected with the graft member and a free end opposed thereto. A belt retaining structure is provided at the stent free end. A belt is releasably retained in the belt retaining structure and is configured to constrain the stent free end independent of the stent connection end.
In another aspect, the invention provides a method of securing at least one end of a graft within a vessel. The method comprises: positioning within the vessel a stent-graft comprising a single segment stent and a graft with a connection end of the stent connected to an end of the graft, the stent having a free end opposite the connection end, the stent free end including a belt retaining structure with a belt releasably retained thereabout; deploying the stent connection end within the vessel; repositioning the stent-graft within the vessel; and releasing the belt to deploy the free end of the stent. In one aspect, the invention provides a stent-graft system comprising a graft member and a stent having a connection end interconnected with the graft member and a free end opposed thereto. A belt retaining structure is provided at the stent free end. A belt is releasably retained in the belt retaining structure and is configured to constrain the stent free end independent of the stent connection end. In another aspect, the invention provides a method of securing at least one end of a graft within a vessel. The method comprises: positioning within the vessel a stent-graft comprising a stent and a graft with a connection end of the stent connected to an end of the graft, the stent having a free end opposite the connection end, the stent free end including a belt retaining structure with a belt releasably retained thereabout; deploying the stent connection end within the vessel; repositioning the stent-graft within the vessel; and releasing the belt to deploy the free end of the stent. Other aspects and advantages of embodiments of the present invention will be apparent from the detailed description of the invention provided hereinafter.
Brief Description of the Drawings
Fig. 1 shows a portion of an endovascular graft according to an embodiment of the present invention in a contracted state for delivery through a catheter.
Fig. 2 shows a flat pattern of an embodiment of a stent in accordance with the present invention. Fig. 3 shows a portion of an endovascular graft according to an embodiment of the present invention partially deployed within an aortic arch of the patient.
Fig. 4 shows the endovascular graft portion of Fig. 3 fully deployed within the internal vasculature of the patient.
Fig. 5 shows a portion of an endovascular graft according to an embodiment of the present invention in a contracted state for delivery through a catheter.
Fig. 6 shows a flat pattern of an embodiment of a stent in accordance with the present invention.
Fig. 7 shows a flat pattern of an alternative embodiment of a stent in accordance with the present invention. Fig. 8 shows a flat pattern of another alternative embodiment of a stent in accordance with the present invention.
Fig. 9 shows a portion of an endovascular graft according to an embodiment of the present invention partially deployed within the internal vasculature of the patient. Fig. 10 shows the endovascular graft portion of Fig. 9 fully deployed within the internal vasculature of the patient.
Fig. 1 1 shows a portion of an endovascular graft according to an embodiment of the present invention partially deployed within an aortic arch of the patient. Fig. 12 is an isometric view of a pivot fitting in accordance with another embodiment of the present invention.
Fig. 13 is an end view of the pivot fitting of Fig. 12.
Fig. 14 is a cross-sectional view along the line 14-14 in Fig. 13. Fig. 15 is a cross-sectional view similar to Fig. 14 illustrating schematically a stent thereon in a contracted state.
Fig. 16 is a cross-sectional view similar to Fig. 14 illustrating schematically a stent thereon in a partially deployed state.
Fig. 17 is a perspective view illustrating a stent in the partially deployed state of Fig. 16.
Detailed Description
Although the invention is illustrated and described herein with reference to specific embodiments, the invention is not intended to be limited to the details shown. Rather, various modifications may be made in the details within the scope and range of equivalents of the claims and without departing from the invention.
Referring to Fig. 1 , a portion of an illustrative endovascular graft 10 is shown in its contracted configuration. Unless otherwise stated, the term "graft" or "endovascular graft" is used herein to refer to a prosthesis capable of repairing and/or replacing diseased vessels or portions thereof, including generally tubular and bifurcated devices and any components attached or integral thereto. For purposes of illustration, the graft embodiments described herein may be used in the endovascular treatment of abdominal aortic aneurysms (AAA) or thoracic aortic aneurysms, however, other applications are within the scope of the present invention. For the purposes of this application, with reference to endovascular graft devices, the term "proximal" describes the end of the graft that will be oriented towards the oncoming flow of bodily fluid, typically blood, when the device is deployed within a body passageway. The term "distal" therefore describes the graft end opposite the proximal end. Finally, while the drawings in the various figures are accurate representations of the various embodiments of the present invention, the proportions of the various components thereof are not necessarily shown to exact scale within and among or between any given figure(s).
An end of the graft 10 is illustrated and may represent the proximal or distal end of the graft 10. The graft 10 includes a generally tubular structure or graft body section 13 comprised of one or more layers of fusible material, such as expanded polytetrafluoroethylene (ePTFE). An inflatable cuff 16 is disposed at or near the end 14 of graft body section 13. A neck portion 23 is disposed in the vicinity of graft body section end 14 and serves as an additional means to help seal the deployed graft against the inside of a body passageway. Graft body section 13 forms a longitudinal lumen 22 configured to confine a flow of fluid therethrough.
An attachment ring 24 is affixed to or integrally formed in graft body section 13, or as shown in Fig. 1 , at or near graft body section end 14 and neck portion 23. In the embodiment of Fig. 1 , attachment ring 24 is a serpentine ring structure comprising apices 28. Other embodiments of attachment ring 24 may take different configurations. Attachment ring 24 may be made from any suitable material that permits expansion from a constrained state, most usefully a shape memory alloy having superelastic properties such as nickel titanium (NiTi). Other suitable attachment ring 24 materials include stainless steel, nickel-cobalt alloys such as MP35N, tantalum and its alloys, polymeric materials, composites, and the like. Attachment ring 24 (as well as all stents and attachment rings described herein) may be configured to self-expand from the illustrated radially constrained state.
Some apices 28 may also comprise a attachment ring connector element not shown). The number of connector elements may vary and can be distributed, for example, on every apex, every third or fourth apex, or any other pattern are within the scope of the present invention.
Graft 10 further comprises one or more stents 40 having, in the deployed state (see Fig. 4), a generally free end 42 and a connection end 44. Figs. 1 -4 illustrate a proximal stent 40, but the stents 40 may additionally or alternatively be provided on the distal end of the graft 10. In the present embodiment, the stent 40 is desirably for use in an angulated or curved lumen and is a short aspect raito stent including a single segement. By single segment stent, it is meant that the stent 40 includes single lengths of struts 41 between the free end 42 and a connection end 44.
As shown in Figs. 1 -4, stent 40 is typically, though not necessarily, made a part of graft 10 by having the connection end 44 affixed or connected to attachment ring 24 via connector elements as described in detail below. The connection end 44 of stent 40 may also be affixed or embedded directly to or in neck portion 23 and/or other portions of graft body section 13. In addition, the attachment ring and the stent may not be mechanically or otherwise fastened to one another but rather unified, formed of a monolithic piece of material, such as NiTi. This configuration of stent 40, attachment ring 24, neck portion 23, and cuff
16 helps to separate the sealing function of cuff 16, which requires conformation and apposition to the vessel wall within which graft 10 is deployed without excessive radial force, from the anchoring function of stent 40 (attachment ring 24 and neck portion 23 play intermediate roles). As will be described in more detail hereinafter, the stents 40 of the present invention permit improved positioning of the graft 10 prior to stent anchoring, thereby facilitating better placement and sealing of the graft 10.
Referring to Figs. 2-4, each stent 40 of the present invention generally comprises a series of interconnected struts 41. The struts 41 can have various configurations and lengths. Each stent 40 further comprises stent connector elements 48 at the connection end 44 thereof. The stent connector elements 48 are configured to be affixed or otherwise connected to attachment ring connector elements via coupling members (not shown), for example, threads or wires. The stents 40 may be manufactured from any suitable material, including the materials suitable for attachment ring 24. When manufactured from a shape memory alloy having superelastic properties such as NiTi, the stents 40 may be configured to self-expand upon release from the contracted state. The strut structure is often formed as a flat structure, as illustrated in Fig. 2, and thereafter, wrapped and connected in a cylindrical or other configuration, as illustrated in Fig. 1 . Each stent 40 includes one or more barbs 43. A barb 43 can be any outwardly directed protuberance, typically terminating in a sharp point that is capable of at least partially penetrating a body passageway in which graft 10 is deployed (typically the initial and medial layers of a blood vessel such as the abdominal aorta). The number of barbs, the length of each barb, each barb angle, and the barb orientation may vary from barb to barb within a single stent 40 or between multiple stents 40 within a single graft. Although the various barbs 43 (and tuck pads 45 discussed below) may be attached to or fixed on the stent struts 41 , it is preferred that they be integrally formed as part of the stent struts 41 , as shown in the various figures.
When stent 40 is deployed in the abdominal aorta, for example, typically in a location proximal to the aneurysm and any diseased tissue, barbs 43 are designed to work in conjunction with the distally-ohented blood flow field in this location to penetrate tissue and prevent axial migration of graft 10. As such, the barbs 43 in the Fig. 1 embodiment are oriented distally with respect to graft body section 13. However, the number, dimensions, configuration and orientation of barbs 43 may vary significantly, yet be within the scope of the present invention. Struts 41 may also comprise optional integral tuck pads 45 disposed opposite each barb 43. During preparation of graft 10 (and therefore the stents 40) into its reduced diameter delivery configuration, each barb 43 is placed behind a corresponding strut 41 and/or optional tuck pad 45, if present, to thereby prevent the barbs 43 from contacting the inside of a delivery sheath or catheter during delivery of the device and from undesired contact with the inside of a vessel wall. As described in U.S. Patent No. 6,761 ,733 to Chobotov et al., the complete disclosure of which is incorporated herein by reference, an initial stage release belt 35 disposed about the struts 41 retain the stent 40 in this delivery configuration. The initial stage release belts 35 retain the contracted stent 40 on a guidewire chassis 12 or the like.
The number of initial stage belts 35 varies in accordance with the structure of the stent 40. The stent 40 as illustrated in Figs. 1 -4 is a single segment and includes only one initial stage belt 35 about the proximal end of the stent 40. The stent 40 of the present invention includes a belt retaining structure 50 provided along the crowns 47 at the free end 42 of the stent 40. In the embodiment illustrated in Figs. 1 and 3-4, the belt retaining structure 50 includes a plurality of mushroom shaped connectors 52 extending from the crowns 47. The mushroom shaped connectors 52 may be provided at each crown 47, as illustrated, or in any configuration with respect to the crowns 47. Referring to Figs. 1 and 5, a releasable secondary stage belt 53 is positionable about the mushroom shaped connectors 52 to retain the stent free end 42 in a contracted state until the secondary stage belt 53 is released, for example, via a release wire 55. In the embodiment illustrated in Fig. 2, the belt retaining structure 50 includes a through hole 54 provided in a plurality of the crowns 47. A releasable belt (not shown) is threaded through the through holes 54 and pulled tight to retain the stent free end 42 in a contracted state until the belt is released. Other belt retaining structures 50 along the stent free end 42 may also be utilized. As shown in Fig. 3, upon release of the initial stage belts 35, the stent connection end 44, the attachment ring 24, and the graft 10 expand while the secondary stage belt 53 engages the belt retaining structure 50 and retains the stent free end 42 in the generally contracted condition. The stent connection end 44 and the graft 10 expand based on the self expanding nature of the stent 40 and also the force of the distal fluid flow into the graft 10. The struts 41 and barbs 43 are configured such that when the belt retaining structure 50 is in place and the stent free end 42 is restrained, the barbs 43 do not extend sufficiently radially to engage the vessel wall 20, but instead remain spaced therefrom. As such, the graft 10 and stent 40 may be moved and repositioned without the barbs 43 engaging and damaging the vessel wall 20. In at least one embodiment of the invention, the barbs 43 are axially positioned closer to the stent free end 42 than the stent connection end 44 to further ensure the barbs 43 will not contact the vessel wall 20 in the partially deployed state.
Once the stent 40 and graft 10 are positioned as desired, the release wire 55 may be pulled to release the secondary stage belt 53 from the belt retaining structure 50, thereby allowing the stent 40 to fully deploy as illustrated in Fig. 4. Upon full deployment, the struts 41 are free to fully radially expand such that the barbs 43 engage the vessel wall 20 in a normal manner.
In addition to facilitating manual movement and repositioning of the graft 10 and stent 40, the staged deployment of the stent 40 also facilitates self-alignment of the stent 40 and graft 10. As explained above, upon release of the initial stage belts 35, the graft 10 is free to expand and distal fluid flow flows into the graft 10 and creates a "windsock" effect. That is, the distal fluid flow expands the graft 10 and applies a slight distal force upon the graft 10. This distal force helps to align the graft 10 and the stent 40 within the vessel.
This self alignment is particularly advantageous during deployment of a stent graft within an angulated vessel, for example, in the aortic arch. Referring to Fig. 3, the stent 40 is illustrated partially deployed in an aortic arch 25. The delivery guidewire chassis 12 contacts the vessel wall 20 and does not remain coaxial with respect to the arch 25. As such, in the initial delivery position, the stent 40 may be cocked or otherwise misaligned with respect to the vessel wall 20. In a prior art single stage deployment, the stent would expand and the barbs would engage the vessel wall even if the stent was misaligned. With the stent 40 of the present invention, the initial stage belt(s) 35 are released and the stent 40 is partially deployed. The distal fluid flow flows into the graft 10 and creates the windsock effect, thereby pulling the graft 10 and stent 40 into alignment with the flow and thereby the vessel wall 20. Referring to Fig. 5, a portion of an illustrative endovascular graft 1 10, that may include a stent with multiple segments, is shown in its contracted configuration. Unless otherwise stated, the term "graft" or "endovascular graft" is used herein to refer to a prosthesis capable of repairing and/or replacing diseased vessels or portions thereof, including generally tubular and bifurcated devices and any components attached or integral thereto. For purposes of illustration, the graft embodiments described herein may be used in the endovascular treatment of abdominal aortic aneurysms (AAA) or thoracic aortic aneurysms, however, other applications are within the scope of the present invention. For the purposes of this application, with reference to endovascular graft devices, the term "proximal" describes the end of the graft that will be oriented towards the oncoming flow of bodily fluid, typically blood, when the device is deployed within a body passageway. The term "distal" therefore describes the graft end opposite the proximal end. Finally, while the drawings in the various figures are accurate representations of the various embodiments of the present invention, the proportions of the various components thereof are not necessarily shown to exact scale within and among or between any given figure(s).
An end of the graft 1 10 is illustrated and may represent the proximal or distal end of the graft 1 10. The graft 1 10 includes a generally tubular structure or graft body section 1 13 comprised of one or more layers of fusible material, such as expanded polytetrafluoroethylene (ePTFE). An inflatable cuff 1 16 is disposed at or near the end 1 14 of graft body section 1 13. A neck portion 123 is disposed in the vicinity of graft body section end 1 14 and serves as an additional means to help seal the deployed graft against the inside of a body passageway. Graft body section 1 13 forms a longitudinal lumen 122 configured to confine a flow of fluid therethrough.
A attachment ring 124 is affixed to or integrally formed in graft body section 1 13, or as shown in Fig. 5, at or near graft body section end 1 14 and neck portion 123. In the embodiment of Fig. 5, attachment ring 124 is a serpentine ring structure comprising apices 128. Other embodiments of attachment ring 124 may take different configurations. Attachment ring 124 may be made from any suitable material that permits expansion from a constrained state, most usefully a shape memory alloy having superelastic properties such as nickel titanium (NiTi). Other suitable attachment ring 124 materials include stainless steel, nickel-cobalt alloys such as MP35N, tantalum and its alloys, polymeric materials, composites, and the like. Attachment ring 124 (as well as all stents and attachment rings described herein) may be configured to self-expand from the illustrated radially constrained state. Some apices 128 may also comprise a attachment ring connector element
130 (see Figs. 9 and 10). The number of connector elements 130 may vary and can be distributed, for example, on every apex, every third or fourth apex, or any other pattern are within the scope of the present invention.
Graft 1 10 further comprises one or more stents 140 having, in the deployed state (see Fig. 10), a generally free end 142 and a connection end 144. Figs. 5 and 9-10 illustrate a proximal stent 140, but the stents 140 may additionally or alternatively be provided on the distal end of the graft 1 10. In the case of a bifurcated graft, a stent 140 may be provided on the distal end of each leg of the bifurcated graft. As shown in Figs. 5 and 9-10, stent 140 is typically, though not necessarily, made a part of graft 1 10 by having the connection end 144 affixed or connected to attachment ring 124 via connector elements as described in detail below. The connection end 144 of stent 140 may also be affixed or embedded directly to or in neck portion 123 and/or other portions of graft body section 1 13. In addition, the attachment ring and the stent may not be mechanically or otherwise fastened to one another but rather unified, formed of a monolithic piece of material, such as NiTi.
This configuration of stent 140, attachment ring 124, neck portion 123, and cuff 1 16 helps to separate the sealing function of cuff 1 16, which requires conformation and apposition to the vessel wall within which graft 1 10 is deployed without excessive radial force, from the anchoring function of stent 140 (attachment ring 124 and neck portion 123 play intermediate roles). As will be described in more detail hereinafter, the stents 140 of the present invention permit improved positioning of the graft 1 10 prior to stent anchoring, thereby facilitating better placement and sealing of the graft 1 10.
Referring to Figs. 6-8, each stent 140 of the present invention generally comprises a series of interconnected struts 141. As illustrated, the struts 141 can have various configurations and lengths. Each stent 140 further comprises stent connector elements 148 at the connection end 144 thereof. The stent connector elements 148 are configured to be affixed or otherwise connected to attachment ring connector elements 130 via coupling members (not shown), for example, threads or wires. The stents 140 may be manufactured from any suitable material, including the materials suitable for attachment ring 124. When manufactured from a shape memory alloy having superelastic properties such as NiTi, the stents 140 may be configured to self-expand upon release from the contracted state. The strut structure is often formed as a flat structure, as illustrated in Figs. 6-8, and thereafter, wrapped and connected in a cylindrical or other configuration, as illustrated in Fig. 5.
Each stent 140 includes one or more barbs 143. A barb 143 can be any outwardly directed protuberance, typically terminating in a sharp point that is capable of at least partially penetrating a body passageway in which graft 1 10 is deployed (typically the initial and medial layers of a blood vessel such as the abdominal aorta). The number of barbs, the length of each barb, each barb angle, and the barb orientation may vary from barb to barb within a single stent 140 or between multiple stents 140 within a single graft. Although the various barbs 143 (and tuck pads 145 discussed below) may be attached to or fixed on the stent struts 141 , it is preferred that they be integrally formed as part of the stent struts 141 , as shown in the various figures.
When stent 140 is deployed in the abdominal aorta, for example, typically in a location proximal to the aneurysm and any diseased tissue, barbs 143 are designed to work in conjunction with the distally-ohented blood flow field in this location to penetrate tissue and prevent axial migration of graft 1 10. As such, the barbs 143 in the Fig. 5 embodiment are oriented distally with respect to graft body section 1 13. However, the number, dimensions, configuration and orientation of barbs 143 may vary significantly, yet be within the scope of the present invention.
Struts 141 may also comprise optional integral tuck pads 145 disposed opposite each barb 143. During preparation of graft 1 10 (and therefore the stents 140) into its reduced diameter delivery configuration, each barb 143 is placed behind a corresponding strut 141 and/or optional tuck pad 145, if present, to thereby prevent the barbs 143 from contacting the inside of a delivery sheath or catheter during delivery of the device and from undesired contact with the inside of a vessel wall. As described in U.S. Patent No. 6,761 ,733 to Chobotov et al., an initial stage release belt 135 disposed about the struts 141 retain the stent 140 in this delivery configuration. The initial stage release belts 135 retain the contracted stent 140 on a guidewire chassis 1 12 or the like.
The number of initial stage belts 135 varies in accordance with the structure of the stent 140. For example, the stents 140 as illustrated in Figs. 6 and 8 have proximal and distal segments and two corresponding initial stage belts 135, one about the proximal segment and one about the distal segment, are used to secure the stent 140 as shown in Fig. 5. In shorter stents 140 having a single segment, like the stent 140 illustrated in Fig. 7, a single initial stage belt 135 is typically used to secure the stent 140. Upon deployment of the stent 140, by releasing the initial stage belt(s) 135, the radial expansion of stent 140 results in a displacement of struts 141 so that the distance between them increases. As the struts 141 separate, the barbs 143 are freed from behind the struts 141 and optional tuck pads 145, if present, and engage the wall of the vessel being treated. To enhance the engagement of the barbs 143 in the vessel wall 120, the barbs 143 may be designed to work in conjunction with the distally-ohented blood flow field, that is, the barbs 143 are oriented distally, however, they do not have to be. In the illustrative embodiment, the barbs 143 at the proximal end are oriented distally, while the barbs 143 at the distal end are oriented proximally.
While secure engagement of the barbs 143 in the vessel wall 120 is desirable to prevent axial migration of graft 1 10, such engagement is generally permanent and not subject to modification. Attempts to reposition the stent 140 or graft 1 10 after engagement of the barbs 143 in the vessel wall 120 may cause tearing or other damage to the vessel wall 120.
Referring to Figs. 6-8, each stent 140 of the present invention includes a belt retaining structure 150 provided along the crowns 147 at the free end 142 of the stent 140. In the embodiments illustrated in Figs. 6 and 7, the belt retaining structure 150 includes a plurality of mushroom shaped connectors 152 extending from the crowns 147. The mushroom shaped connectors 152 may be provided at each crown 147, as illustrated, or in any configuration with respect to the crowns 147. Referring to Figs. 5 and 9, a releasable secondary stage belt 153 is positionable about the mushroom shaped connectors 152 to retain the stent free end 142 in a contracted state until the secondary stage belt 153 is released, for example, via a release wire 155. In the embodiment illustrated in Fig. 8, the belt retaining structure 150 includes a through hole 154 provided in a plurality of the crowns 147. A releasable belt (not shown) is threaded through the through holes 154 and pulled tight to retain the stent free end 142 in a contracted state until the belt is released. Other belt retaining structures 150 along the stent free end 142 may also be utilized.
As shown in Fig. 9, upon release of the initial stage belts 135, the stent connection end 144, the attachment ring 124, and the graft 1 10 expand while the secondary stage belt 153 engages the belt retaining structure 150 and retains the stent free end 142 in the generally contracted condition. The stent connection end 144 and the graft 1 10 expand based on the self expanding nature of the stent 140 and also the force of the distal fluid flow into the graft 1 10. The struts 141 and barbs 143 are configured such that when the belt retaining structure 150 is in place and the stent free end 142 is restrained, the barbs 143 do not extend sufficiently radially to engage the vessel wall 120, but instead remain spaced therefrom. As such, the graft 1 10 and stent 140 may be moved and repositioned without the barbs 143 engaging and damaging the vessel wall 120. In at least one embodiment of the invention, the barbs 143 are axially positioned closer to the stent free end 142 than the stent connection end 144 to further ensure the barbs 143 will not contact the vessel wall 120 in the partially deployed state. Once the stent 140 and graft 1 10 are positioned as desired, the release wire
155 may be pulled to release the secondary stage belt 153 from the belt retaining structure 150, thereby allowing the stent 140 to fully deploy as illustrated in Fig. 10. Upon full deployment, the struts 141 are free to fully radially expand such that the barbs 143 engage the vessel wall 120 in a normal manner. In addition to facilitating manual movement and repositioning of the graft 1 10 and stent 140, the staged deployment of the stent 140 also facilitates self- alignment of the stent 140 and graft 1 10. As explained above, upon release of the initial stage belts 135, the graft 1 10 is free to expand and distal fluid flow flows into the graft 1 10 and creates a "windsock" effect. That is, the distal fluid flow expands the graft 1 10 and applies a slight distal force upon the graft 1 10. This distal force helps to align the graft 1 10 and the stent 140 within the vessel.
This self alignment is particularly advantageous during deployment of a stent graft within an angulated vessel, for example, in the aortic arch. Referring to Fig. 1 1 , the stent 140 is illustrated partially deployed in an aortic arch 125. The delivery guidewire chassis 1 12 contacts the vessel wall 120 and does not remain coaxial with respect to the arch 125. As such, in the initial delivery position, the stent 140 may be cocked or otherwise misaligned with respect to the vessel wall 120. In a prior art single stage deployment, the stent would expand and the barbs would engage the vessel wall even if the stent was misaligned. With the stent 140 of the present invention, the initial stage belt(s) 135 are released and the stent 140 is partially deployed. The distal fluid flow flows into the graft 1 10 and creates the windsock effect, thereby pulling the graft 1 10 and stent 140 into alignment with the flow and thereby the vessel wall 120.
Referring to Figs. 12-17, a pivot fitting 200 configured to assist in the multi- staged deployment of stent 140 will be described. The pivot fitting 200 has a generally cylindrical body 202 with an axial through bore 204 configured to position the fitting 200 about the guidewire chassis 1 12 (see Fig. 17) or the like. A transverse bore 206 is provided to facilitate positioning and attachment of the pivot fitting 200 about the guidewire chassis 1 12 and loading into the delivery catheter (not shown).
The pivot fitting 200 includes an area 208 of reduced cross section extending between a shoulder 210 and a radial belt support member 212. The area 208 is configured to receive the free ends of the stent 140, for example, the mushroom shaped connectors 152 or the crowns 147 with through holes 154. To facilitate passage of the stent members, the radial belt support member 212 includes a plurality of radial slots 214. In the embodiment illustrated in Fig. 17, each radial slot 214 receives the narrow neck portion of a respective mushroom shaped connector 152.
A circumferential groove 216 is provided along the radial surface of the radial belt support member 212. The circumferential groove 216 is configured to receive and maintain the secondary stage belt 153. A belt radial slot 218 is provided in the radial belt support member 212 to facilitate passage of the secondary stage belt 153 from the guidewire chassis 1 12 or the like outward to the circumferential groove 216.
Referring to Fig. 15, in the delivery stage, the stent 140 is compacted with the free end 142 passing through the radial slots 214 in the radial belt support member 212. The secondary stage belt 153 is secured in the circumferential groove 216 and constrains the stent free end 142. Turning to Figs. 16 and 17, upon release of the initial stage release belts 135, the connection end 144 of the stent 140 expands while the free end 142 is retained by the secondary stage belt 153. The opening diameter of the connection end 144 can be controlled by the relation of the outer diameter of area 208 and the inner diameter of the circumferential groove 216 and the length of the portion of the stent free end 142 that extends into area 208. In this partially deployed state, the stent free end 142 is securely retained by the pivot fitting 200, which in turn is connected to the guidewire chassis 1 12. As such, movement of the guidewire chassis 1 12 provides relatively precise control of the position of the stent 140. Once the stent 140 is positioned in a desired position, the secondary stage belt 153 is released and the stent free end 142 disengages from the pivot fitting 200 and expands. The pivot fitting 200 remains connected to the guidewire chassis 1 12 and is removed upon removal thereof.
While preferred embodiments of the invention have been shown and described herein, it will be understood that such embodiments are provided by way of example only. Numerous variations, changes and substitutions will occur to those skilled in the art without departing from the spirit of the invention. Accordingly, it is intended that the appended claims cover all such variations as fall within the spirit and scope of the invention.

Claims

What is claimed is:
1. A stent-graft system comprising: a graft member; a single segment stent having a connection end interconnected with the graft member and a free end opposed thereto; a belt retaining structure provided at the stent free end; and a belt releasably engaging the belt retaining structure and configured to constrain the stent free end substantially independent of the stent connection end.
2. The stent-graft system according to claim 1 wherein the stent comprises a plurality of struts extending between the connection end and the free end.
3. The stent-graft system according to claim 2 wherein crowns adjoin respective adjacent struts at the free end of the stent.
4. The stent-graft system according to claim 3 wherein the belt retaining structure includes a plurality of through holes extending through the crowns.
5. The stent-graft system according to claim 4 wherein the belt is threaded through a plurality of the through holes.
6. The stent-graft system according to claim 3 wherein the belt retaining structure includes at least two mushroom shaped connectors extending from respective crowns.
7. The stent-graft system according to claim 2 wherein one or more barbs extend from the stent struts.
8. The stent-graft system according to claim 7 wherein the barbs are positioned closer to the stent free end than the stent connection end.
9. The stent-graft system according to claim 1 wherein the belt is releasably secured by a release wire.
10. The stent-graft system according to claim 1 wherein at least one additional belt is releasably secured about the stent between the connection end and the free end and is releasable independent from the belt.
1 1. The stent-graft system according to claim 1 wherein the stent connection end includes a plurality of connection elements configured for attachment to corresponding connection members on the tubular graft.
12. A method of securing at least one end of a stent-graft within a vessel, comprising: positioning within the vessel a stent-graft comprising a single segment stent and a graft with a connection end of the stent connected to an end of the graft, the stent having a free end opposite the connection end, the stent free end including a belt retaining structure with a belt releasably retained thereabout; deploying the stent connection end within the vessel; repositioning the stent-graft within the vessel, if needed; and releasing the belt to deploy the free end of the stent.
13. The method according to claim 12 wherein the vessel is a thoracic aorta.
14. The method according to claim 12 wherein the vessel is an abdominal aorta.
15. The method according to claim 12 wherein the step of repositioning the stent-graft within the vessel includes moving the stent, the graft or a combination of the stent and the graft.
16. The method according to claim 12 wherein the step of repositioning the stent-graft within the vessel includes allowing a fluid flow through the vessel to enter within the graft to self-align the stent and graft.
17. The method according to claim 12 wherein the step of deploying the stent connection end within the vessel includes releasing an additional belt constraining the stent connection end.
18. A stent-graft system comprising: a graft member; a stent having a connection end interconnected with the graft member and a free end opposed thereto; a belt retaining structure provided at the stent free end; and a belt releasably engaging the belt retaining structure and configured to constrain the stent free end substantially independent of the stent connection end.
19. The stent-graft system according to claim 18 wherein the stent comprises a plurality of struts extending between the connection end and the free end.
20. The stent-graft system according to claim 19 wherein crowns adjoin respective adjacent struts at the free end of the stent.
21. The stent-graft system according to claim 20 wherein the belt retaining structure includes a plurality of through holes extending through the crowns.
22. The stent-graft system according to claim 21 wherein the belt is threaded through a plurality of the through holes.
23. The stent-graft system according to claim 20 wherein the belt retaining structure includes at least two mushroom shaped connectors extending from respective crowns.
24. The stent-graft system according to claim 19 wherein one or more barbs extend from the stent struts.
25. The stent-graft system according to claim 24 wherein the barbs are positioned closer to the stent free end than the stent connection end.
26. The stent-graft system according to claim 18 wherein the belt is releasably secured by a release wire.
27. The stent-graft system according to claim 18 wherein at least one additional belt is releasably secured about the stent between the connection end and the free end and is releasable independent from the belt.
28. The stent-graft system according to claim 18 wherein the stent connection end includes a plurality of connection elements configured for attachment to corresponding connection members on the tubular graft.
29. The stent-graft system according to claim 18 further comprising a pivot fitting configured to retain the belt about the belt retaining structure such that the belt pivotally secures the stent free end to the pivot fitting.
30. The stent-graft system according to claim 29 wherein the pivot fitting is attached to a graft delivery member.
31. The stent-graft system according to claim 30 wherein the pivot fitting includes an axial bore configured to receive the graft delivery member.
32. The stent-graft system according to claim 29 wherein the pivot fitting includes a radial belt support member with a circumferential groove configured to receive the belt.
33. The stent-graft system according to claim 32 wherein the radial belt support member includes a plurality of radial slots configured to receive respective portions of the stent free end.
34. The stent-graft system according to claim 32 wherein the pivot fitting includes an area of reduced cross section configured to receive the belt retaining structure and a diameter of the stent connection end in the partially deployed state is determined at least in part by the relationship of an outer diameter of the area of reduced cross section and an inner diameter of the circumferential groove.
35. A method of securing at least one end of a stent-graft within a vessel, comprising: positioning within the vessel a stent-graft comprising a stent and a graft with a connection end of the stent connected to an end of the graft, the stent having a free end opposite the connection end, the stent free end including a belt retaining structure with a belt releasably retained thereabout; deploying the stent connection end within the vessel; repositioning the stent-graft within the vessel, if needed; and releasing the belt to deploy the free end of the stent.
36. The method according to claim 35 wherein the vessel is a thoracic aorta.
37. The method according to claim 35 wherein the vessel is an abdominal aorta.
38. The method according to claim 35 wherein the step of repositioning the stent-graft within the vessel includes moving the stent, the graft or a combination of the stent and the graft.
39. The method according to claim 35 wherein the step of repositioning the stent-graft within the vessel includes allowing a fluid flow through the vessel to enter within the graft to self-align the stent and graft.
40. The method according to claim 35 wherein the step of deploying the stent connection end within the vessel includes releasing an additional belt constraining the stent connection end.
PCT/US2008/077727 2007-09-26 2008-09-25 Alignment stent apparatus and method WO2009042796A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08834027.8A EP2194919A4 (en) 2007-09-26 2008-09-25 Alignment stent apparatus and method

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/861,746 US20090082845A1 (en) 2007-09-26 2007-09-26 Alignment stent apparatus and method
US11/861,716 US8066755B2 (en) 2007-09-26 2007-09-26 System and method of pivoted stent deployment
US11/861,746 2007-09-26
US11/861,716 2007-09-26

Publications (2)

Publication Number Publication Date
WO2009042796A2 true WO2009042796A2 (en) 2009-04-02
WO2009042796A3 WO2009042796A3 (en) 2009-05-14

Family

ID=40512109

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/077727 WO2009042796A2 (en) 2007-09-26 2008-09-25 Alignment stent apparatus and method

Country Status (2)

Country Link
EP (1) EP2194919A4 (en)
WO (1) WO2009042796A2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2111828A2 (en) * 2008-04-25 2009-10-28 Cordis Corporation Stent Attachment and Deployment Mechanism
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
AU2015215940B2 (en) * 2008-04-25 2017-04-20 Cardinal Health 529, Llc Stent attachment and deployment mechanism
US10159557B2 (en) 2007-10-04 2018-12-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
EP3184083B1 (en) 2010-05-27 2019-02-20 Medtronic Vascular Galway Catheter assembly with prosthesis crimping and prosthesis retaining accessories
CN111035486A (en) * 2019-12-25 2020-04-21 上海微创心脉医疗科技股份有限公司 Stent delivery system and method of loading stents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2202800A1 (en) * 1991-04-11 1992-10-12 Alec A. Piplani Endovascular graft having bifurcation and apparatus and method for deploying the same
US6350277B1 (en) * 1999-01-15 2002-02-26 Scimed Life Systems, Inc. Stents with temporary retaining bands
DK1263349T3 (en) * 2000-03-14 2009-10-19 Cook Inc Endovascular stent graft
US20040138734A1 (en) * 2001-04-11 2004-07-15 Trivascular, Inc. Delivery system and method for bifurcated graft
US6761733B2 (en) * 2001-04-11 2004-07-13 Trivascular, Inc. Delivery system and method for bifurcated endovascular graft
US7828838B2 (en) * 2001-11-28 2010-11-09 Aptus Endosystems, Inc. Devices, systems, and methods for prosthesis delivery and implantation, including a prosthesis assembly
AU2002360765C1 (en) * 2001-12-20 2009-06-11 Trivascular, Inc. Advanced endovascular graft
US7147661B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
FR2863160B1 (en) * 2003-12-09 2006-03-03 Perouse Laboratoires DEVICE FOR TREATING A BLOOD VESSEL AND METHOD FOR PREPARING THE SAME

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None
See also references of EP2194919A4

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10682222B2 (en) 2007-10-04 2020-06-16 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US10159557B2 (en) 2007-10-04 2018-12-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
EP2263617A1 (en) * 2008-04-25 2010-12-22 Cordis Corporation Stent attachment and deployment mechanism
AU2015215940B2 (en) * 2008-04-25 2017-04-20 Cardinal Health 529, Llc Stent attachment and deployment mechanism
EP2111828A3 (en) * 2008-04-25 2010-09-01 Cordis Corporation Stent Attachment and Deployment Mechanism
EP2111828A2 (en) * 2008-04-25 2009-10-28 Cordis Corporation Stent Attachment and Deployment Mechanism
US10813779B2 (en) 2008-04-25 2020-10-27 CARDINAL HEALTH SWITZERLAND 515 GmbH Stent attachment and deployment mechanism
US11589987B2 (en) 2010-05-27 2023-02-28 Medtronic Vascular Galway Unlimited Company Catheter assembly with prosthesis crimping and prosthesis retaining accessories
EP3184083B1 (en) 2010-05-27 2019-02-20 Medtronic Vascular Galway Catheter assembly with prosthesis crimping and prosthesis retaining accessories
EP3184083B2 (en) 2010-05-27 2024-01-03 Medtronic Vascular Galway Catheter assembly with prosthesis crimping and prosthesis retaining accessories
US11432925B2 (en) 2010-05-27 2022-09-06 Medtronic Vascular Galway Unlimited Company Catheter assembly with prosthesis crimping and prosthesis retaining accessories
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
CN111035486A (en) * 2019-12-25 2020-04-21 上海微创心脉医疗科技股份有限公司 Stent delivery system and method of loading stents
CN111035486B (en) * 2019-12-25 2024-01-23 上海微创心脉医疗科技(集团)股份有限公司 Stent delivery system and method of loading stents

Also Published As

Publication number Publication date
EP2194919A2 (en) 2010-06-16
WO2009042796A3 (en) 2009-05-14
EP2194919A4 (en) 2013-05-08

Similar Documents

Publication Publication Date Title
US8663309B2 (en) Asymmetric stent apparatus and method
US20090082845A1 (en) Alignment stent apparatus and method
US9713523B2 (en) System and method of pivoted stent deployment
JP6353593B2 (en) Endoluminal prosthesis with a bifurcated section that can be turned
US10646365B2 (en) Delivery system and method for self-centering a proximal end of a stent graft
JP4825665B2 (en) Lumen device with enhanced mounting characteristics
US6918926B2 (en) System for transrenal/intraostial fixation of endovascular prosthesis
US20090082847A1 (en) System and method of securing stent barbs
EP2111828B1 (en) Stent attachment and deployment mechanism
US7955380B2 (en) Prosthesis fixation apparatus and methods
EP2606853B1 (en) Hybrid aortic arch replacement
US10335265B2 (en) Ring on a closed web stent-graft for use in tip capture
EP1364626A1 (en) Endovascular stent graft and fixation cuff
US8083789B2 (en) Securement assembly and method for expandable endovascular device
US20090082841A1 (en) Apparatus for securing stent barbs
JP2020508086A (en) Sheath contracted stent graft delivery system and method of use
US20100030318A1 (en) Dual Capture Device for Stent Graft Delivery System and Method for Capturing a Stent Graft
JP2008507331A (en) Device and method for delivering an intravascular stent-graft having a portion that is not longitudinally supported
JP2008029839A (en) Twisted anchoring barb for stent of abdominal aortic aneurysm (aaa) device
US20200345527A1 (en) Delivery system and method for self-centering a proximal end of a stent graft
EP2194919A2 (en) Alignment stent apparatus and method
EP2702960B1 (en) Endoluminal prosthesis and delivery device
US20110295358A1 (en) Endoluminal prosthesis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08834027

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008834027

Country of ref document: EP